We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Accused of ‘Hiding the Ball’ in Generic Seroquel Approvals
FDA Accused of ‘Hiding the Ball’ in Generic Seroquel Approvals
April 10, 2012
A bevy of generic manufacturers have launched generic versions of AstraZeneca’s blockbuster antipsychotic Seroquel soon after a federal judge dismissed the drugmaker’s attempts to block competition.